Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;25(9):1073-1081.
doi: 10.2174/1389201025666230830125147.

The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities

Affiliations
Review

The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities

Jeetendra Kumar Gupta. Curr Pharm Biotechnol. 2024.

Abstract

The expression of aldose reductase leads to a variety of biological and pathological effects. It is a multifunctional enzyme which has a tendency to reduce aldehydes to the corresponding sugar.alcohol. In diabetic conditions, the aldose reductase enzyme converts glucose into sorbitol using nicotinamide adenine dinucleotide phosphate as a cofactor. It is a key enzyme in polyol pathway which is a surrogate course of glucose metabolism. The polyol pathway has a significant impact on the aetiology of complications in individuals with end-stage diabetes. The exorbitant level of sorbitol leads to the accumulation of intracellular reactive oxygen species in diabetic heart, neurons, kidneys, eyes and other vasculatures, leading to many complications and pathogenesis. Recently, the pathophysiological role of aldose reductase has been explored with multifarious perspectives. Research on aldose reductase suggest that besides implying in diabetic complications, the enzyme also turns down the lipid-derived aldehydes as well as their glutathione conjugates. Although aldose reductase has certain lucrative role in detoxification of toxic lipid aldehydes, its overexpression leads to intracellular accumulation of sorbitol which is involved in secondary diabetic complications, such as neuropathy, cataractogenesis, nephropathy, retinopathy and cardiovascular pathogenesis. Osmotic upset and oxidative stress are produced by aldose reductase via the polyol pathway. The inhibition of aldose reductase alters the activation of transcription factors like NF-ƙB. Moreover, in many preclinical studies, aldose reductase inhibitors have been observed to reduce inflammation-related impediments, such as asthma, sepsis and colon cancer, in diabetic subjects. Targeting aldose reductase can bestow a novel cognizance for this primordial enzyme as an ingenious strategy to prevent diabetic complications and associated morbidities. In this review article, the significance of aldose reductase is briefly discussed along with their prospective applications in other afflictions.

Keywords: Diabetes; aldose reductase; nephropathy; neuropathy; polyol pathway.; retinopathy; sorbitol.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hers H.G.; Le mécanisme de la transformation de glucose en fructose par les vésicules séminales. Biochim Biophys Acta 1956,22(1),202-203 - DOI - PubMed
    1. Ramana K.V.; Aldose reductase: New insights for an old enzyme. Biomol Concepts 2011,2(1-2),103-114 - DOI - PubMed
    1. Van Heyningen R.; Formation of polyols by the lens of the rat with `Sugar' cataract. Nature 1956,184(4681),194-195
    1. Chalk C.; Benstead T.J.; Moore F.; Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Libr 2007,2010(1),CD004572 - DOI - PubMed
    1. Kinoshita J.H.; Dvornik D.; Kramil M.; Gabbay K.H.; The effect of an aldose reductase inhibitor on the galactose-exposed rabbit lens. Biochim Biophys Acta, Gen Subj 1968,158(3),472-475 - DOI - PubMed